Multiple system atrophy (MSA) is a rare, progressively fatal neurological disorder, caused by cell loss in specific areas of the brain that leads to a variety of symptoms, particularly affecting the functions of the motor system (cerebellar and/or parkinsonian symptoms) and the autonomic nervous system. There are no treatments that can halt or slow the progression of the disease. This 6th International MSA Congress follows previous congresses held in Salerno in 2016, Toulouse in 2012, Innsbruck in 2007, Rome in 2004 and London in 1997. Numerous discoveries have been made in MSA research since the last meeting and this congress will be a unique opportunity to update and share the knowledge in this field. Exciting discoveries suggest that MSA is a “prion-like” disorder that has a characteristic pre-motor phase and natural history.
The objective of this international congress is to bring together basic and clinical neuroscientists to address these new discoveries and to generate ideas for future research in this long-neglected field. The congress will comprise a series of invited lectures given by world-renowned international experts on MSA. Topics will include advances in neuropathological and molecular features, imaging, and emerging therapeutic strategies for MSA. The lectures will update on the pathophysiology, clinical presentation and progression of the disease; novel imaging techniques and the search for disease biomarkers for early diagnosis; and treatment, clinical trials for MSA and plans for future studies. The congress venue will be New York University Langone Medical Center in New York City. It will be a two-day event, Thursday and Friday, March 1-2, 2018. The main target audience will be national and international autonomic disorders specialists, movement disorders specialists, neurologists, neurodegeneration specialists, and basic and clinical neuroscientists.